Clinical Trial Update: A Dose-ranging Study of Fluticasone Furoate (FF) [Phase 2]

View source ↗

Summary

A Phase 2 dose-ranging trial of Fluticasone Furoate in asthma was completed. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Fluticasone Furoate (fluticasone furoate)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2015-04-27